Back to Blog

Welcoming Dr. George Grammatopoulos

Formus Labs is pleased to announce that internationally regarded, Oxford-trained orthopaedic surgeon, Dr. George Grammatopoulos, has joined our growing clinical advisory board. Dr. Grammatopoulos will provide expert feedback on ongoing clinical evaluations and further development of Formus Labs’ AI-automated 3D pre-operative planning software.

Dr. Grammatopoulos, BSc (Hons), MBBS (Hons), DPhil, FRCS (Tr&Orth), currently serves as a Staff Orthopaedic Surgeon in the Arthroplasty and Hip Preservation Team at The Ottawa Hospital, and an Associate Professor at the University of Ottawa. As the resident research supervisor at the University of Ottawa’s Orthopaedic Training programme, he plays a critical role in supervising a number of under-and post-graduate students across a range of orthopaedic health-related projects.

“As both a highly experienced surgeon and an esteemed academic, Dr. Grammatopoulos brings a wealth of invaluable knowledge as we continue to maximise the clinical benefits and overall usability of the platform”, affirmed Formus CEO, Dr. Ju Zhang.

A prolific researcher, Dr. Grammatopoulos ranks in the top one percent of global experts in the field of hip replacement arthroplasty and is the holder of multiple national and international awards, including the 2018 Hip Society Frank Stinchfield Award. Having published over 75 peer-reviewed articles across his career, his primary research interests include pre-operative patient optimisation, cup orientation, and postoperative outcomes following hip surgery.

“Dr. Grammatopoulos’s complementary areas of interest make him an ideal partner and a perfect fit for our clinical advisory board. As a renowned expert on hip replacement arthroplasty, his input will help ensure the Formus platform lives up to our core mission – empowering surgeons to deliver optimal patient outcomes”, continued Dr. Zhang.

With a healthy runway and a growing clinical advisory board comprised of some of the world’s leading orthopaedic surgeons, the future of orthopaedic planning is in good hands.

More from the Lab

Formus Labs Hip Platform Receives FDA Clearance!

Formus Labs today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Formus Hip as the first “automated radiological image processing software” for hip replacement pre-op planning.

Read Story

Internationally Renowned Orthopaedic Surgeon Thought Leaders Join Formus Labs’ Clinical Advisory and Development Board.

Formus Labs, creator of the world's first automated 3D, AI-enabled pre-operative planner for joint replacement surgeries, today announces the expansion of its clinical advisory board. Three global thought leaders in the field of arthroplasty, Dr. J. Bohannon Mason, Dr. Atul Kamath and Dr. James A. Germano will help shape the next generation of Formus Labs’ innovative planning technology and will support the company’s expansion into new markets.

Read Story

Formus Labs, a Pioneering Developer of Orthopedic Surgery Planning Technology, Hires Ex-Johnson & Johnson Executive, Polly Teevan, To Lead Global Commercial Strategy

Formus Labs, creator of the world's first fully-automated 3D planner for joint replacement surgeries, today announced it has hired Polly Teevan as Chief Marketing Officer. Teevan will oversee global commercial and marketing strategy, and lead Formus to expand its presence in the US and international markets leveraging her deep customer relationships, industry knowledge and commercial experience.

Read Story

Subscribe for the latest news and product updates

We will never share your email address with third parties.